ADELE CRITCHLEY Patent Agent

703-827-3822 571-395-8753 acritchley@whda.com

BiographyMs. Critchley has international experience in prosecutingpatent applications specializing in the areas ofpharmaceuticals, biotechnology, medical devices,biochemistry, polymers, cell and molecular biology, andfluorescent imaging technologies. She has also assisted indrafting patentability, validity and infringement opinions.

While serving as a Technical Specialist for a Japanese IP law firm, she assisted ininfringement and invalidation litigation suits as well as freedom-to-operate seaches andopinions. She served as a co-leader of the Biotechnology, Chemistry andPharmaceutical Technical Specialist team and was involved in the supervision andtraining of 13 other team members. In recognition of this work, she was awarded"Outstanding Effort Award" in 2011.

Outside of the office, Ms. Critchley enjoys snowboarding, running, cooking, and karaoke.

Related ServicesPatent ProsecutionLegal Opinions and Counseling

Related TechnologiesChemistry, Chemical Engineering and Materials ScienceLife SciencesMechanical Engineering

EducationB.Sc. (Honors) Pharmacology, 2007, The University of Manchester (UK) M.Sc. Immunology and Immunogenetics, 2008, The University of Manchester (UK) LL.M. Intellectual Property Law, 2014, The University of Manchester (UK)

© 2022 Westerman Hattori Daniels & Adrian, LLP. All rights reserved.

LanguagesEnglishJapanese

AdmissionsU. S. Patent and Trademark Office, 2015

PublicationsGot A Lot To Say? Unfortunately, CAFC Affirm A Word Limit Will Not Prevent EstoppelUnder 35 USC §315(e)(1), 4.1.2022Lets’ B. Cereus, no reasonable fact finder could find an expectation of success basedon the teachings of a prior art reference that failed to achieve that which the inventorsucceeds, 12.6.2021Note Quite Game Over as Bot M8 Receive a 1-Up from the CAFC, 7.23.2021If it cannot be made, it does not exist!, 5.11.2021Sorry Doc, no Patent Term Adjustment under the C-delay Provision! , 3.1.2021What Does It Mean To Be Human?, 11.26.2020CAFC Remands Back To PTAB Instructing Them To Conduct The Analysis AndCorrect The Mistakes In Wearable Technology IPR Case, 7.22.2020The limitations of a “wherein” clause, 10.15.2019The Patent-Ineligibility trend continues to be infectious…, 10.29.2018What do dioxaborinanes and benzoxaboroles have in common? They both exhibitactivity against fungi, and so Anacor failed before the Federal Circuit, which could nothave been fun-guys…, 5.17.2018Bayer left hard up when CAFC reversed district courts final judgment with some stiffwords for the lower court., 11.9.2017Alice: ‘This is impossible’ (Alice in Wonderland 2010): Alice (Corp. Pty. Ltd. v. CLSBank Int’l,), aid’s in striking yet another blow against the pursuit of diagnostic testmethod, 6.26.2017When the acts of one are attributable to the other., 2/16/2017Patentee Likely (Con)vexed After The Court of Appeals Fails To See Through TheSame Lens as them…, 9.17.2015The act of contemplation then creates the thing created (Isaac D'Israeli). , 4.21.2015What Do a Resealable Cartridge for Low Pressure Liquid Chromatography and aSoda-Pop Bottle and Cap have in Common?, 9.23.2014"Nothing Lost but Nothing Gained: Generic Producer Evades Infringement but Fails toInvalidate Patent under §112", CAFC Alert, April 3, 2014, 4.3.2014

© 2022 Westerman Hattori Daniels & Adrian, LLP. All rights reserved.